StockData
Evolus, Inc. logo

Evolus, Inc. (EOLS) stock

EOLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$7.07+0.38 (+5.68%)

Close on Nov 18, 2026Market cap $466.98MP/E –Yield –

Evolus market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Evolus's market cap was $489.82M on Nov 11, 2026, against $463.73M a year earlier. Over the last 5 years it ranged from $267.18M to $1.03B, with a median of $540.67M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$489.82M+13.7%
2025Dec 31, 2025$430.70M-38.3%
2024Dec 31, 2024$698.29M+16.2%
2023Dec 29, 2023$601.18M+42.5%
2022Dec 30, 2022$421.94M+16.7%
2021Dec 31, 2021$361.66M+218.9%
2020Dec 31, 2020$113.40M-66.0%
2019Dec 31, 2019$333.77M+2.8%
2018Dec 31, 2018$324.57M–

More Evolus figures

See a number that looks wrong?